Sestrin-2 Levels and Insulin Resistance

Sestrin-2 Levels and Insulin Resistance in Childhood Obesity

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT06779721

Enrollment

Registered

2025-01-16

Start date

2021-06-20

Completion date

2022-02-15

Last updated

2025-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obese Adolescents

Keywords

Antioxidant, childhood obesity, insulin resistance, sestrin-2, oxidative stress

Brief summary

The aim of this study is to evaluate sestrin-2 levels in children with obesity

Interventions

OTHERSestrin-2

Sestrin-2 levels were studied in three different groups

Study design

Observational model

CASE_CONTROL

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

10 Years to 18 Years

Healthy volunteers

Yes

Inclusion criteria

Obese adolescents Body mass index above the 95th percentile BMI Z-score above 2

Exclusion criteria

Primary hyperlipidemia Primary liver disease Hypothyroidism Diabetes

Design outcomes

Primary

Measure	Time frame
Evaluation of sestrin-2 levels in obese and healthy participants	From enrollment to the end of 6 months

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026